| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Arundathy N. Pandite is Chief Medical Officer at STTK. Arundathy N. Pandite's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $745K at current prices.
The STTK filings lean toward selling, a net 60,000 shares.
Arundathy N. Pandite has 14 Form 4 filings on record from December 2020 to June 2026, all as Chief Medical Officer at Shattuck Labs (STTK), 2020–2026.
The 20 reported transactions were 7 tax withholdings, 6 option or other derivative awards, 3 stock awards and 2 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $409K.
The largest open-market sale was 30,000 shares of STTK at an average $7.01 on June 30, 2026, about $210K.
Both sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.